Prot #CE01-301: A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients with Community-Acquired Bacte

Project: Research project

Project Details

Effective start/end date3/25/143/25/17


  • INC Research, LLC (Prot #CE01-301 // Prot #CE01-301)
  • Cempra Pharmaceuticals, Inc. (Prot #CE01-301 // Prot #CE01-301)